-
1
Integrated genomic analyses of ovarian carcinoma
Published 2012“…A catalogue of molecular aberrations that cause ovarian cancer is critical for developing and deploying therapies that will improve patients’ lives. …”
Get full text
Article -
2
Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
Published 2016“…The majority of ovarian tumors eventually recur in a drug resistant form. …”
Get full text
Get full text
Article -
3
UNRAVELING THE ORIGIN OF OVERIONIZED PLASMA IN THE GALACTIC SUPERNOVA REMNANT W49B
Published 2015“…Using these results, we find that W49B is overionized in the west, with a gradient of overionization increasing from east to west. …”
Get full text
Get full text
Article -
4
Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models
Published 2017“…Intraperitoneal (IP) chemotherapy for ovarian cancer treatment prolongs overall survival by 16 months compared to intravenous chemotherapy but is not widely practiced due to catheter-related complications and complexity of administration. …”
Get full text
Get full text
Get full text
Article -
5
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4
Published 2014“…We used TPN in vivo to evaluate inhibitor of DNA binding 4 (ID4) as a novel oncogene. Treatment of ovarian tumor–bearing mice with ID4-specific TPN suppressed growth of established tumors and significantly improved survival. …”
Get full text
Get full text
Get full text
Article -
6
The Ligand Binding Domain of GCNF Is Not Required for Repression of Pluripotency Genes in Mouse Fetal Ovarian Germ Cells
Published 2013“…Here we demonstrate that Gcnf is expressed in fetal ovarian germ cells, peaking at E14.5, when Oct4 and Nanog are silenced. …”
Get full text
Get full text
Article -
7
Layer-by-layer assembled fluorescent probes in the second near-infrared window for systemic delivery and detection of ovarian cancer
Published 2017“…Successful detection of orthotopic ovarian tumors is achieved by in vivo NIR-II imaging and confirmed by ex vivo microscopic imaging. …”
Get full text
Get full text
Get full text
Get full text
Get full text
Article -
8
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Published 2012“…One such gene, PAX8, is focally amplified in 16% of high-grade serous ovarian cancers and expressed at higher levels in ovarian tumors. …”
Get full text
Get full text
Article -
9
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
Published 2013“…Seventy-five percent of patients with epithelial ovarian cancer present with advanced-stage disease that is extensively disseminated intraperitoneally and prognosticates the poorest outcomes. …”
Get full text
Article -
10
A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
Published 2017“…Compound 2 effectively kills hormone-dependent, cisplatin-resistant human ovarian cancer cells, inhibiting IDO by transcriptional deregulation of the auto-crine-signaling loop IDO-AHR-IL6, which blocks kynurenine production and promotes T-cell proliferation. …”
Get full text
Get full text
Get full text
Get full text
Article -
11
A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell–scaffold interaction and chemotherapeutic resistance of anticancer drugs
Published 2014“…The cancer cell–nanofiber scaffold construct was cultured for 5 days, and the ovarian cancer cells had actively proliferative potential. …”
Get full text
Article -
12
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival bearing tumors derived from Brca1-deficient ovarian cancer cells
Published 2011“…Inhibition of the DNA repair enzyme poly(ADP-ribose) polymerase 1 (PARP1) with small molecules has been shown to be an effective treatment for ovarian cancer with BRCA mutations. Here, we report the in vivo administration of siRNA to Parp1 in mouse models of ovarian cancer. …”
Get full text
Get full text
Get full text
Article -
13
-
14
Naval Engineering A National Naval Obligation
Published 2002Subjects: “…Naval Architecture and Marine Engineering…”
Get full text
-
15
-
16
-
17
-
18
-
19
-
20